Antiplatelet pretreatment effects in patients with non-ST-segment elevation acute coronary syndromes in a center without daily 24 hours access to the catheter laboratory
Pretreatment was associated with a lower incidence of IE in NSTE-ACS patients with lower rates of MI before CAG and type 4b MI, without a significant increase in BE.
Authors
- Marcelo Rizzo (ORCID: https://orcid.org/0000-0002-2649-3072)
- P Rojas-Flores (ORCID: https://orcid.org/0009-0006-9809-7112)
- Gabriel Torres-Ruiz
- Victor García-Hernando (ORCID: https://orcid.org/0000-0003-1190-6679)
- Josep Guindo-Soldevila (ORCID: https://orcid.org/0009-0001-8002-0858)
- Nuria Mallofré-Vila (ORCID: https://orcid.org/0009-0008-6060-6414)
- Pablo Carrión Montaner (ORCID: https://orcid.org/0009-0002-0493-7637)
- Jordi Cahís-Vela
- Mario Sutil-Vega
- Meritxell Lloreda-Surribas
- Eduard Bosch-Peligero
- Pablo Del Castillo-Vázquez
- Gala Caixal-Vila
- Antoni Martínez-Rubio
- Daniel Valcárcel-Paz
Institutions
- Institute of Research and Innovation Parc Tauli (ES)
Publication Details
- Journal
- Heart & Lung
- Published
- 2026-02-09
- DOI
- https://doi.org/10.1016/j.hrtlng.2026.102728
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00